Fully Human Domain Antibody Therapeutics: The Best of Both Worlds
By combining the therapeutic benefits of small molecule drugs
with those of fully human antibodies, Domain Antibodies are
expected to have strong therapeutic and commercial potential.
Robert Connelly at Domantis (September 2005)
Keywords: Fully Human Domain Antibody Therapeutics benefits small molecule drugs strong therapeutic commercial potential